Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Ozempic is a medication that’s receiving attention for its role in weight loss. It works by helping control appetite and blood sugar levels. But knowing what dose of Ozempic is best for weight ...

Zepbound (tirzepatide) is a prescription injection that comes as a single-dose pen or single-dose vial. If your doctor prescribes Zepbound to you and you need to travel, there are certain things ...

It’s the active ingredient in type 2 diabetes drug Ozempic and the higher-dose obesity drug Wegovy. Since Wegovy’s FDA approval in 2021, Ozempic has often been prescribed off-label for weight ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Novo Nordisk’s Ozempic (semaglutide ... study evaluating a higher dose of semaglutide in adults with obesity. Among patients who adhered to treatment in the phase 3b STEP UP trial, those receiving the ...

Novo Nordisk has shared positive headline results from a late-stage study evaluating a higher dose of its GLP-1 receptor agonist semaglutide in adults with obesity. The phase 3b STEP UP trial has been ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients ...

“This approval for Ozempic allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of adults and could have serious consequences if ...